#ASMESCMID on Twitter 

For information on the 2018 ASM/ESCMID Conference, please visit: www.escmid.org

Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by National and International bodies. There are relatively few agents in developmental pipelines and a paucity of identified microbiological targets that can be exploited for drug development. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development for AMR. 

Access 2017 ASM/ESCMID Conference materials 

 

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

94883